Endocrine and Metabolic Dysfunction
Endocrine dysfunction represents a critical but often overlooked dimension of ME/CFS pathophysiology. The endocrine system orchestrates fundamental physiological processes including stress response, energy metabolism, circadian rhythms, reproduction, and immune modulation. Disruption of these hormonal axes provides mechanistic explanations for the multi-system nature of ME/CFS symptoms and connects seemingly disparate clinical features into a coherent pathophysiological framework.
The landmark NIH deep phenotyping study by Walitt et al. (2024) documented central nervous system dysfunction with direct implications for neuroendocrine regulation (Walitt et al. 2024). Complementing this neurological evidence, recent studies have identified specific endocrine abnormalities spanning the hypothalamic-pituitary-adrenal (HPA) axis, thyroid function, sex hormones, growth factors, glucose metabolism, and circadian regulation. These findings reveal that ME/CFS involves coordinated dysfunction across multiple endocrine systems rather than isolated hormonal deficits.
This chapter examines six major endocrine systems implicated in ME/CFS pathophysiology. The HPA axis shows characteristic blunting with hypersensitive feedback, contributing to stress intolerance and immune dysregulation. Thyroid function abnormalities, particularly the βLow T3 Syndrome,β affect cellular metabolism despite normal TSH levels. Sex hormone dysregulation explains the striking female predominance and menstrual cycle exacerbations. Growth hormone and IGF-1 deficiencies contribute to muscle dysfunction and metabolic impairment. Insulin resistance and cerebral glucose hypometabolism connect to the energy deficit discussed in Chapter Energy Metabolism and Mitochondrial Function. Finally, circadian rhythm disruption integrates with the sleep abnormalities and autonomic dysfunction detailed in Chapters Neurological and Neurocognitive Dysfunction and Cardiovascular Dysfunction. Chapter Integrative Models and Multi-System Pathophysiology synthesizes these endocrine connections with immune and metabolic systems into comprehensive models of ME/CFS pathophysiology.
Understanding endocrine dysfunction is essential for several reasons. First, hormonal abnormalities provide measurable biomarkers for diagnosis and disease monitoring. Second, endocrine pathways mechanistically link immune activation (Chapter Immune System Dysfunction) to metabolic dysfunction (Chapter Energy Metabolism and Mitochondrial Function). Third, hormonal dysregulation explains symptom patterns such as post-exertional malaise, orthostatic intolerance, and cognitive impairment that define the clinical presentation. Finally, endocrine interventions represent potential therapeutic targets, though current evidence remains mixed and requires careful evaluation.
For patients: read the HPA-axis and thyroid sections to understand stress intolerance and low-energy symptoms. Women should also read the sex-hormones and menstrual-cycle sections for cycle-linked flares.
For caregivers: read the HPA-axis and thyroid sections to understand fatigue and stress reactivity. The melatonin/circadian section explains sleep disruption.
For clinicians: read the thyroid, insulin/glucose, and sex-hormone sections for testable abnormalities and the low-T3 pattern. The integrated endocrine-metabolic model links hormonal findings to treatment.
For researchers: read the growth-hormone/IGF-1 and neurosteroid/menstrual sections plus the integrated model. These cross-link to Chapter Integrative Models and Multi-System Pathophysiology.